PRESS RELEASE – Due to the overwhelming demand and popularity of the XCELL PRP system, APEX Biologix is temporarily out of stock until next week (week of October 1, 2018).

FOR IMMEDIATE RELEASE

Salt Lake City, Utah, September 25, 2018 – APEX Biologix would like to formally thank all their clients in making the launch of their XCELL PRP system so successful. Due to the overwhelming demand and popularity of the XCELL PRP system, they are temporarily out of stock until the week of October 1, 2018. Their new PRP system, which hit the market in July, has experienced an influx of orders due to the ease-of-use, economical price, and high concentration levels of PRP solutions produced.

Without the support from their existing clients, XCELL PRP could not have made the impact it did. “The launch of our XCELL PRP system was received even better than we anticipated. We are excited about what this system brings to the market and the extremely positive feedback we have received from our physicians and their staff.,” stated Dan Crane, President of APEX Biologix.
XCELL PRP is revolutionary in its ability to maximize platelet count using a controlled push method during the PRP process. The XCELL PRP system has a specialized concentrating device that helps shorten total processing times and reduces human error, compared to other systems on the market. This new system can produce both leukocyte-rich and leukocyte-poor PRP.

“Our goal was to provide a cost-effective PRP system to the market without sacrificing purity or quality. When our initial independent test came back, it confirmed what a high-quality system we have,” said Richard Rosenthal, MD, APEX Biologix’s Medical Director.

The XCELL PRP system was tested by Intermountain Healthcare Laboratories in Salt Lake City. In 35 back-to-back samples they found, on average, the XCELL PRP generates a platelet enrichment of 8.93 times base, with over 7.5 billion platelets per a 6.5 ML dosage and an average of 71.15% platelet recovery rate. The XCELL PRP has shown superior results compared to other popular PRP kits in the U.S.

APEX Biologix expects to have the XCELL PRP kits back in stock the first week of October 2018. Until that time, they will continue to take orders and will fill back orders as soon as inventory comes in. All backorders will be expedited without any additional shipping charges to customers. APEX Biologix works to continually put the needs of their clients first and has adjusted the supply to reflect the demand.

“We would like to thank all of our customers who are currently using the new XCELL PRP system and for their valuable feedback and reviews. Although this has caused a very brief shortage, it has shown us that we’ve produced a product that the industry has been needing for quite some time. The popularity of this system continues to grow, and as such, we’ll continue to improve our processes.”

APEX Biologix is a national leader in providing a wide variety of regenerative medicine products to medical practices, including allograft vials, amnion membrane patches, bone marrow kits, and PRP systems. In addition to selling regenerative medicine products, APEX Biologix consults and educates physicians on the science and promotion of regenerative medicine. For more information about XCELL PRP or other regenerative medicine solutions contact APEX Biologix at (844) 897-4910 or by email at info@apexbiologix.com.

XXX